How schools can optimise support for children with ADHD

(University of Exeter) New research gives the clearest guidance yet on how schools can best support children with ADHD to improve symptoms and maximise their academic outcomes.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news

Related Links:

In conclusion, while rs-fMRI use in clinical neuroradiology practice is limited, enthusiasm appears to be quite high and there are several possible avenues in which further research and development may facilitate its penetration into clinical practice. Introduction Techniques for quantifying spatial and temporal brain activity have developed rapidly since the first demonstrations that MRI could be used to measure modulations in blood oxygen level dependent (BOLD) tissue contrast (1). The observation that MRI could be used to monitor temporally correlated low-frequency activity fluctuations in spatially remote brain a...
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Sarah Kaye1, Mark H. Sundman2, Eric E. Hall3*, Ethan Williams4, Kirtida Patel5 and Caroline J. Ketcham3 1Mailman Research Center, McLean Hospital, Belmont, MA, United States 2Department of Psychology, University of Arizona, Tucson, AZ, United States 3Department of Exercise Science, Elon University, Elon, NC, United States 4Office of the Dean of Students, Elon University, Elon, NC, United States 5Department of Sports Medicine, Elon University, Elon, NC, United States Previous consensus statements on sports concussion have highlighted the importance of Attention Deficit Hyperactivity Disorder (ADHD) and loss of...
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Conclusion: the STAR project demonstrated the feasibility of the TwiCs approach for testing interventions for children with ADHD.What is Known:•Attention deficit hyperactivity disorder (ADHD) is a lifelong condition associated with considerable costs to ADHD stakeholders. Children are at risk of negative outcomes and in need of pre-emptive strategies•The long-term effectiveness and acceptability of recommended treatments to improve outcomes remains in doubtWhat is New:•A small-scale test of the design demonstrated that the Trials within Cohorts (TwiCs) approach is feasible and can make a useful contribution ...
Source: European Journal of Pediatrics - Category: Pediatrics Source Type: research
For the first time, children in the United States will have a non-drug option for treating attention deficit hyperactivity disorder (ADHD). The FDA just cleared the Monarch external Trigeminal Nerve Stimulation (eTNS) System from NeuroSigma, a Los An...
Source: Medgadget - Category: Medical Devices Authors: Tags: Neurology Pediatrics Psychiatry Rehab Source Type: blogs
The U.S. Food and Drug Administration permitted marketing of the first medical device to treat attention deficit hyperactivity disorder (ADHD). The prescription-only device, called the Monarch external Trigeminal Nerve Stimulation (eTNS) System, is indicated for patients ages 7 to12 years old who are not currently taking prescription ADHD medication and is the first non-drug treatment for ADHD granted marketing authorization by the FDA.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
What do you all think about this? FDA signs off on first medical device for treating ADHD in children As diagnosis rates of ADHD among children skyrocket, a new medical device for the treatment of ADHD could soon hit the market. www.usatoday.com Called the Monarch external Trigeminal Nerve Stimulation (eTNS) System, the prescription-only device is for children ages 7 to 12 who are not taking ADHD prescription medication. The Monarch eTNS – an instrument the siz...
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Psychiatry Source Type: forums
We examined the association between paternal intelligence and ASD, considering co-occurring intellectual disability (ID) and attention-deficit hyper-activity disorder (ADHD).
Source: Journal of the American Academy of Child and Adolescent Psychiatry - Category: Psychiatry Authors: Tags: New Research Source Type: research
On Friday, the Food and Drug Administration (FDA) announced that it is permitting the marketing of the first medical device for the treatment of attention-deficit/hyperactivity disorder (ADHD). The device, called the Monarch external Trigeminal Nerve Stimulation (eTNS) System, will be available by prescription only and is indicated for children aged 7 to 12 years who are not taking prescription ADHD medications.“This new device offers a safe, nondrug option for treatment of ADHD in pediatric patients through the use of mild nerve stimulation, a first of its kind,” said Carlos Peña, Ph.D., director of the...
Source: Psychiatr News - Category: Psychiatry Tags: ADHD attention-deficit/hyperactivity disorder child and adolescent psychiatry FDA FDA approval Food and Drug Administration medical device neuromodulation TNS Trigeminal nerve stimulation Source Type: research
The US Food and Drug Administration has granted marketing authorization for the Monarch external trigeminal nerve stimulation system to treat ADHD in patients between the ages of 7 and 12 years.FDA Approvals
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Alert Source Type: news
The Monarch external Trigeminal Nerve Stimulation (eTNS) System made history last week after it became the first device to win a nod from FDA to treat attention deficit hyperactivity disorder (ADHD). It should be noted the technology has had CE mark since 2015. Monarch was developed by NeuroSigma and is indicated to help treat 7 to 12-year-olds suffering from ADHD. What makes this de novo clearance from FDA so significant is that typically pharmaceutical solutions are used to treat patients suffering from the neurological disorder. Monarch is about the size of a cellphone. The device generates a low-level electrical pulse ...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Source Type: news
More News: Academia | ADHD | Children | International Medicine & Public Health | Schools | Science